↓ Skip to main content

The comparative efficacy and risk of harms of the intravenous and subcutaneous formulations of trastuzumab in patients with HER2-positive breast cancer: a rapid review

Overview of attention for article published in Systematic Reviews, December 2019
Altmetric Badge

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The comparative efficacy and risk of harms of the intravenous and subcutaneous formulations of trastuzumab in patients with HER2-positive breast cancer: a rapid review
Published in
Systematic Reviews, December 2019
DOI 10.1186/s13643-019-1235-x
Authors

Miriam Van den Nest, Anna Glechner, Maria Gold, Gerald Gartlehner

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 24%
Student > Bachelor 2 12%
Student > Ph. D. Student 2 12%
Lecturer 1 6%
Professor 1 6%
Other 2 12%
Unknown 5 29%
Readers by discipline Count As %
Medicine and Dentistry 6 35%
Economics, Econometrics and Finance 2 12%
Nursing and Health Professions 1 6%
Immunology and Microbiology 1 6%
Social Sciences 1 6%
Other 1 6%
Unknown 5 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2019.
All research outputs
#12,490,159
of 16,379,900 outputs
Outputs from Systematic Reviews
#1,257
of 1,478 outputs
Outputs of similar age
#261,168
of 385,858 outputs
Outputs of similar age from Systematic Reviews
#231
of 264 outputs
Altmetric has tracked 16,379,900 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,478 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.7. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 385,858 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 264 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.